Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.370
-0.145-2.63%
Volume:508.44K
Turnover:2.65M
Market Cap:4.38B
PE:-22.97
High:5.505
Open:5.300
Low:4.975
Close:5.515
52wk High:9.850
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:2.68
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.03
PE(LYR):-22.97
PS:4.01

Loading ...

ASCLETIS-B Shares Surge Over 5% in Early Trading as GIC Boosts Stake to 7% and U.S. Phase II Study Completes Enrollment

Stock News
·
May 21

GLP-1 Medications, Now Used by 10% of Americans, Are Reshaping Pharma, Food, Beverage, and Dining Sectors

Deep News
·
May 21

Pharmaceutical Giant Bristol-Myers Squibb Expands AI Integration, Deploys Claude Platform to 30,000 Employees

Stock News
·
May 20

Top 50 Global Pharmaceutical Brands Ranked by Value, Featuring 10 Chinese Companies

Deep News
·
May 19

Puli Pharmaceutical Faces Investor Compensation After First-Instance Court Victory in Fraud Case

Deep News
·
May 19

Piramal Pharma and Botanix Forge Manufacturing Pact for Hyperhidrosis Drug API

Deep News
·
May 19

Regeneron Plunges on Melanoma Drug Trial Miss

Stock News
·
May 18

PEGBIO CO-B (02565) Surges 150% in Late Trading Following Exclusive Commercial Deal for Padakine in Mainland China

Stock News
·
May 18

New Batch of Investor Compensation Claims Filed Against *ST Poly Pharm in Court Following Previous Successful Verdicts

Deep News
·
May 13

OCUMENSION-B (01477) Grants Stock Options and Awards

Stock News
·
May 12

Ocumension Therapeutics grants 7,932,095 share options at HK$ 7.1 exercise price

Reuters
·
May 12

GIC Private Limited Increases Stake in Ascletis-B (01672) by 122,000 Shares at HK$16.612 Each

Stock News
·
May 12

Insilico Medicine to List on HKEX, Joining AI Drug Development Peers, Backed by BlackRock as Key Investor, Near-Term Revenue Reliant on Upfront Payments, Long-Term Prospects Remain Uncertain

Deep News
·
May 12

BAIYUNSHAN PH's Subsidiary Receives Approval for Supplemental Applications of Cefuroxime Sodium and Candesartan Cilexetil Tablets

Stock News
·
May 11

LAEKNA-B Shares Surge Over 10% in Afternoon Trading as Qilu Pharmaceutical Advances LAE002 NDA; Company Poised for Upfront and Milestone Payments

Stock News
·
May 11

Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Deal

Deep News
·
May 07

Hainan Poly Pharm Investor Claims Submitted for Court Filing Following Prior Successful Verdict

Deep News
·
May 07

LAEKNA-B Shares Surge Over 5% in Late Trading as Qilu Pharma Advances Domestic Application for LAE002

Stock News
·
May 07

Pharmaceutical Supply Chain Shows Clear Signs of Upturn, Driven by Domestic and International Demand

Stock News
·
May 07

Ocumension Maintains Share Structure in April; Option Lapses Trim Outstanding Grants

Bulletin Express
·
May 06